ToF-SIMS analysis of dexamethasone distribution in the isolated perfused eye

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 11, 2011, Pages 8413-8419

  Mains, Jenifer ^a   Wilson, Clive G ^a   Urquhart, Andrew ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; LENS; NONHUMAN; PRIORITY JOURNAL; RETINA; SHEEP; TIME OF FLIGHT MASS SPECTROMETRY; TISSUE PREPARATION; VITREOUS BODY; ANIMAL; EYE; INTRAVITREAL DRUG ADMINISTRATION; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; TISSUE DISTRIBUTION;

ANIMALS; DEXAMETHASONE; EYE; GLUCOCORTICOIDS; INTRAVITREAL INJECTIONS; SHEEP, DOMESTIC; SPECTROMETRY, MASS, SECONDARY ION; TISSUE DISTRIBUTION;

EID: 84855405231     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8199     Document Type: Article

References (49)

1. Notivol R, Bertin D, Amin D, et al. Comparison of topical tobramycin-dexamethasone with dexamethasone-neomycin-polymyxin and neomycin-polymyxin-gramicidin for the control of inflammation after cataract surgery: results of a multicenter, prospective, three-arm, randomized, double-masked, controlled, parallel-group study. Clin Ther. 2004;26:1274-1285.
2. Weijtens O, Schoemaker RC, Cohen AF, et al. Dexamethasone concentration in vitreous and serum after oral administration. Am J Ophthalmol. 1998;125:673-679.
3. Barcia E, Herrero-Vanrell R, Díez A, et al. Downregulation of endotoxin-induced uveitis by intravitreal injection of polylacticglycolic acid (PLGA) microspheres loaded with dexamethasone. Exp Eye Res. 2009;89:238-245.
4. Earla R, Boddu SHS, Cholkar K, et al. Development and validation of a fast and sensitive bioanalytical method for the quantitative determination of glucocorticoids: quantitative measurement of dexamethasone in rabbit ocular matrices by liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal. 2010;52: 525-533.
5. Haller JA, Bandello F, Belfort R, et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 2010; 117:1134-1146.
6. Armaly MF. Statistical attributes of the steroid hypertensive response in the clinically normal eye. Invest Ophthalmol Vis Sci. 1965;4:187-197.
7. Haller JA, Kuppermann BU, Blumenkranz MS, et al. Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol. 2010;128:289-296.
8. Williams GA, Haller JA, Kuppermann BD, et al. Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. Am J Ophthalmol. 2009;147:1048-1054.
9. Eljarrat-Binstock E, Raiskup F, Frucht-Pery J, et al. Transcorneal and transscleral iontophoresis of dexamethasone phosphate using drug loaded hydrogel. J Control Release.2005;106:386-390.
10. Kwak HW, D'Amico DJ. Determination of dexamethasone sodium phosphate in the vitreous by high performance liquid chromatography. Korean J Ophthalmol. 1995;9:79-83.
11. 3H]dexamethasone ophthalmic film delivery systems in the rabbit eye. Int J Pharm. 1988;47:21-30.
12. Baeyens V, Kaltsatos V, Boisramé B, et al. Optimized release of dexamethasone and gentamicin from a soluble ocular insert for the treatment of external ophthalmic infections. J Control Release. 1998;52:215-220.
13. Midelfart A, Dybdahl A, Muller N, et al. Dexamethasone and dexamethasone phosphate detected by H and F NMR spectroscopy in the aqueous humour. Exp Eye Res. 1998;66:327-337.
14. Mason JO 3rd, Nixon PA, White MF. Intravitreal injection of bevacizumab (Avastin) as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol. 2006;142:685-688.
15. Porta M, Allione A. Current approaches and perspectives in the medical treatment of diabetic retinopathy. Pharmacol Ther. 2004; 103:167-177.
16. Ding X, Patel M, Chan C-C. Molecular pathology of age-related macular degeneration. Prog Retin Eye Res. 2008;28:1-18.
17. Wong TY, Liew G, Mitchell P. Clinical update: new treatments for age related macular degeneration. Lancet. 2007;370:204-206.
18. + in rat cerebellum with imaging TOF-SIMS. Appl Surf Sci. 2006;252: 6777-6781.
19. Wu L, Lu X, Kulp KS, et al. Imaging and differentiation of mouse embryo tissues by ToF-SIMS. Int J Mass Spectrom. 2007;260:137-145.
20. Davies OR, Head L, Armitage D, et al. Surface modification of microspheres with steric stabilizing and cationic polymers for gene delivery. Langmuir. 2008;24:7138-7146.
21. Belu AM, Davies MC, Newton JM, et al. TOF-SIMS characterization and imaging of controlled-release drug delivery systems. Anal Chem. 2000;72:5625-5638.
22. Urquhart AJ, Taylor M, Anderson DG, et al. TOF-SIMS analysis of a 576 micropatterned copolymer array to reveal surface moieties that control wettability. Anal Chem. 2007;80:135-142.
23. Shard AG, Davies MC, Tendler SJB, et al. X-ray photoelectron spectroscopy and time-of-flight SIMS investigations of hyaluronic acid derivatives. Langmuir. 1997;13:2808-2814.
24. Marko-Varga G, Fehniger TE, Rezeli M, et al. Drug localization in different lung cancer phenotypes by MALDI mass spectrometry imaging. J Proteomics. 2011;74:982-992.
25. Benninghoven A, Hagenhoff B, Niehuis E. Surface MS: probing real-world samples. Anal Chem. 1993;65:630-640.
26. Mains J, Wilson C, Urquhart A. ToF-SIMS analysis of ocular tissues reveals biochemical differentiation and drug distribution. Eur J Pharm Biopharm. 2011;79:328-333.
27. Shiels IA, Sanderson SD, Taylor SM. Arterially perfused eye model of uveitis. Aust Vet J. 1999;77:100-104.
28. thed. St. Louis: Mosby, 2003:747-784.
29. Simoens P, Ghoshal NG. Arterial supply to the optic nerve and the retina of the sheep. J Anat. 1981;133:481-497.
30. Coo FAM, Zonnenberg BA, Trap NH. Prolonged normothermic perfusion of the isolated bovine eye: initial results. Curr Eye Res. 1993;12:293-301.
31. Wilson WS, Shahidullah M, Millar C. The bovine arterially-perfused eye: an in vitro method for the study of drug mechanisms on IOP, aqueous humour formation and uveal vasculature. Curr Eye Res. 1993;12:609-620.
32. Koeberle MJ, Hughes PM, Skellern GG, et al. Pharmacokinetics and disposition of memantine in the arterially perfused bovine eye. Pharm Res. 2006;23:2781-2798.
33. Feng J, Chan C-M, Weng L-T. Influence of chain sequence structure of polymers on ToF-SIMS spectra. Polymer. 2000;41:2695-2699.
34. Huang HL, Goh SH, Lai DMY, et al. ToF-SIMS studies of poly(methyl methacrylate-co-methacrylic acid), poly(2,2,3,3,3-pentafluoropropyl methacrylate-co-4-vinylpyridine) and their blends. Appl Surf Sci. 2004;227:373-382.
35. Gazi E, Dwyer J, Lockyer N, et al. The combined application of FTIR microspectroscopy and ToF-SIMS imaging in the study of prostate cancer. Faraday Discuss. 2003;126:41-59.
36. Williams TM, Kind AJ, Houghton E, et al. Electrospray collisioninduced dissociation of testosterone and testosterone hydroxy analogs. J Mass Spectrom. 1999;34:206-216.
37. 2 surface. J Am Soc Mass Spectrom. 2001;12: 1286-1295.
38. Belu A, Graham DJ, Castner DG. Time-of-flight secondary ion mass spectrometry: techniques and applications for the characterization of biomaterial surfaces. Biomaterials. 2003;24:3635-3653.
39. Tyler BJ, Rayal G, Castner DG. Multivariate analysis strategies for processing ToF-SIMS images of biomaterials. Biomaterials. 2007; 28:2412-2423.
40. Balazs EA, Denlinger JL. The vitreous. In: Davson H, ed. The Eye. New York: Academic Press; 1984:533-589.
41. Gisladottir S, Loftsson T, Stefansson E. Diffusion characteristics of the vitreous humour and saline solution follow the Stokes Einstein equation. Graefe's Arch Clin Exp Ophthalmol. 2009;247:1677-1684.
42. Gouras P, Hoff M. Retinal function in an isolated perfused mammalian eye. Invest Ophthamol Vis Sci. 1970;9:388-399.
43. Niemeyer G. Retinal research using the perfused mammalian eye. Prog Retina Eye Res. 2001;20:289-318.
44. Fatt I. Flow and diffusion in the vitreous body of the eye. Bull Math Biol. 1975;37:85-90.
45. Xu J, Heys JJ, Barocas VH, et al. Permeability and diffusion in the vitreous humor: implications for drug delivery. Pharm Res. 2000; 17:664-669.
46. Park J, Bungay PM, Lutz RJ, et al. Evaluation of coupled convectivediffusive transport of drugs administered by intravitreal injection and controlled release implant. J Control Release. 2005;105:279-295.
47. Missel P. Hydraulic flow and vascular clearance influences on intravitreal drug delivery. Pharm Res. 2002;19:1636-1647.
48. Stay MS, Xu J, Randolph TW, et al. Computer simulation of convective and diffusive transport of controlled release drugs in the vitreous humor. Pharm Res. 2002;20:96-102.
49. Tan LE, Orilla W, Hughes P, et al. Effects of vitreous liquefaction on intravitreal distribution of sodium fluorescein, fluorescence dextran, and fluorescent microparticles. Invest Ophthalmol Vis Sci. 2011;52:1111-1118.